Drug Shortage Provisions In Draft PDUFA Bill Would Expedite Major Manufacturing Changes
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA would have 60 days to review major changes and could “deem” them compliant with current good manufacturing practices so long as the facility has a plan and resources to achieve full compliance and institutes quality control measures under draft legislation being developed by the House Energy and Commerce Committee.
You may also be interested in...
FDA Pediatric Incentives, Powers Would Become Permanent Under Draft Bill
In the absence of sunset provisions that necessitate periodic reauthorization of the pediatric laws, GAO would report to Congress on a five-year cycle about the accomplishments of the drug programs for children and make recommendations for amendments.
PDUFA Draft Bill Would Broaden FDA’s Mission, Make Guidance Development More Public
FDA would be tasked with protecting public health while promoting economic growth and job creation under a discussion draft from the House authorizing committee. Draft Guidances would be voided if not finalized within a year under the proposal.
PDUFA Draft Bill Would Broaden FDA’s Mission, Make Guidance Development More Public
FDA would be tasked with protecting public health while promoting economic growth and job creation under a discussion draft from the House authorizing committee. Draft Guidances would be voided if not finalized within a year under the proposal.